A randomized phase II study of S-1 versus capecitabine as first-line chemotherapy in the elderly and/or poor performance status patients with recurrent or metastatic gastric cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Capecitabine (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Gastric cancer
- Focus Pharmacogenomic; Therapeutic Use
- 09 Apr 2013 Interim results (n=98) presented at the 104th Annual Meeting of the American Association for Cancer Research.
- 09 Apr 2013 Status changed from recruiting to active, no longer recruiting.
- 18 Jan 2008 New trial record.